Home | Services | Equipment

Directors: Lauri Goodell, MD and David J. Foran, PhD

Histopathology Manager: Julia Arnsdorff

Histopathology and ImagingThe Histopathology shared resource provides high quality, cost effective histopathology services and capitalizes on limited tissue resources to provide Rutgers Cancer Institute of New Jersey members with large collections (tissue microarrays) of human or animal, normal or tumor histology specimens to identify and/or quantify the expression of proteins, mRNAs, and the presence of whole chromosomes as well as individual genes.  State-of-the-art imaging technology is available for Rutgers Cancer Institute members to analyze and archive their histologic specimens.

The specific objectives of this shared resource are:

  • To provide immunohistochemical localization of cells and antigens using well-characterized antibodies in normal and malignant tissues
  • To define optimal conditions for novel, investigator-developed antibodies to localize tissue antigens
  • To provide tissue sections for investigators to procure pure cells from specific microscopic regions of tissue sections using microdissection
  • To assist investigators with all types of staining techniques (IHC, FISH, ISH, Q-dot) needed for visualization of cells/proteins including multi-color labeling
  • To construct TMA blocks for investigator-initiated translational research
  • To provide TMA sections containing large numbers of normal and malignant tissue cores
  • To work in conjunction with the Biomedical Informatics shared resource who provides state of the art imaging technology for analyzing  and archiving histologic biospecimens.


The Histopathology shared resource of Rutgers Cancer Institute of New Jersey is a specialized service facility that supports the cancer research efforts of our members.

This facility is supported primarily by the Cancer Center Support Grant (CCSG) from the National Cancer Institute.  Additional support may be provided from other sources, such as chargeback systems, institutional funding and/or other grants. The support from the CCSG allows the facility to provide benefits to Cancer Center members, such as ensured access to services or subsidies to user rates.

Please remember to acknowledge the valuable services provided by the Histopathology shared resource in your research papers, publications and grant applications. The following acknowledgement statement is recommended:

"This research was supported by the Histopathology shared resource of Rutgers Cancer Institute of New Jersey (P30CA072720)."

(Note: please also consider including the names of individuals from the shared resources if they provided any intellectual input or additional effort.)


precision medicine at Rutgers Cancer Institute




Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health